Global Acarbose Market Report 2019: Market Value is Expected to Reach USD 185 Million in 2026

Global Acarbose Market Report 2019: Market Value is Expected to Reach USD 185 Million in 2026

Acarbose is a white powder API for products such as acarbose capsule chewable tablets and is an α-glucosidase inhibitor product. The medicine used drugs for type 2 diabetes, which is a pseudo-four sugar biosynthesis, can inhibit the small intestine cells activity of α — glucosidase, thereby delaying intestinal oligosaccharide, disaccharide or polysaccharide degradation, delaying the degradation and absorption of glucose and fructose in order to achieve the effect of reducing postprandial blood glucose.

Market Snapshot

This report categorizes the market with various types, applications, companies, and regions. It focuses on the present scenario and the future growth of the global acarbose market, especially in regions like North America, Asia-Pacific, Europe, South America, Middle East and Africa.

It is estimated that the CAGR (Compounded Annual Growth Rate) of the world market in the forecast period will reach 5%, and the total market value is expected to reach USD 185 million in 2026 from USD 131 million in 2019.

Get FREE Sample of Acarbose Market Report at:

https://www.globalmarketmonitor.com/reports/163098-acarbose-market-report-2019.html#download-sample

Competitive Landscape

The major global acarbose market competitors include Pfizer, Beijing Bayer Healthcare, Novartis, Mylan, Squibb, Hikma Pharmaceuticals, GSK, Intra Labs India Pvt Ltd., Emcure, Abbott, Takeda, Bayer Group, CKD Bio Corporation, Bayer Vital GmbH, and etc.

Growth Driver

Globally, the prevalence of increasing diseases and raising awareness and concerns pertaining to the health are the major factors driving the demand for acarbose. Besides, the escalated use of new inventions and enhanced technologies are further fueling the growth of the acarbose market.

Purchase a copy of Acarbose report at:

https://www.globalmarketmonitor.com/reports/163098-acarbose-market-report-2019.html#download-sample

Regional Overview

Regional segmentations include Europe (Germany, France, UK, Russia and Italy), North America (USA, Canada and Mexico), Asia Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil), Argentina, Colombia, etc., And the Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa).In 2018, the global acarbose market was mainly concentrated in the three regions of Asia-Pacific, North America and Europe, with the market share of 26%, 38% and 26% respectively, accounting for a total of 90%. North America is the largest producer, with annual production value exceeds USD 48 million in 2018.

Type Overview

l   Injection

l   Freeze-dried Powder

Application Overview

l   Hospital

l   Clinic

l   Household

Ask for a discount at:

https://www.globalmarketmonitor.com/reports/163098-acarbose-market-report-2019.html#download-sample

l   Base Year: 2018

l   Estimated Year: 2019

l   Forecast Period: 2019 to 2026

Target Audience:

Key Stakeholders

Acarbose Manufacturers

Acarbose Distributors

Acarbose Subcomponent Manufacturers

Acarbose Industry Association

Downstream Vendors

Contact:

Global Market Monitor

One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,

NY 11201, USA

Phone: + 1 (347) 467 7721

Email: info@globalmarketmonitor.com

Web Site: https://www.globalmarketmonitor.com